These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7416748)

  • 1. Inhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones.
    Dobek AS; Klayman DL; Dickson ET; Scovill JP; Tramont EC
    Antimicrob Agents Chemother; 1980 Jul; 18(1):27-36. PubMed ID: 7416748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1- and 3-acetylisoquinoline and related compounds as inhibitors of clinically significant bacteria in vitro.
    Dobek AS; Klayman DL; Dickson ET; Scovill JP; Oster CN
    Arzneimittelforschung; 1983; 33(11):1583-91. PubMed ID: 6686454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial properties of 2-acetylpyridine-1-oxide thiosemicarbazones.
    Dobek AS; Klayman DL; Scovill JP; Dickson ET
    Chemotherapy; 1986; 32(1):25-30. PubMed ID: 3081301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Acetylpyridine thiosemicarbazones XI: 2-(alpha-Hydroxyacetyl)pyridine thiosemicarbazones as antimalarial and antibacterial agents.
    Klayman DL; Lin AJ; Hoch JM; Scovill JP; Lambros C; Dobek AS
    J Pharm Sci; 1984 Dec; 73(12):1763-7. PubMed ID: 6396400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Neisseria gonorrhoeae to 2-acetylpyridine thiosemicarbazones.
    Christenson B; Rodríguez JR; Gorbea HF; Ramírez-Rond CH
    Antimicrob Agents Chemother; 1985 Apr; 27(4):570-3. PubMed ID: 3923924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of imipenem against hospital bacteria].
    Soussy CJ; Duval J
    Presse Med; 1990 Apr; 19(13):583-7. PubMed ID: 2139936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
    Neu HC; Chin NX
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):644-50. PubMed ID: 2506029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the effect of hexetidine in vitro].
    Linzenmeier G
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro.
    Casero RA; Klayman DL; Childs GE; Scovill JP; Desjardins RE
    Antimicrob Agents Chemother; 1980 Aug; 18(2):317-22. PubMed ID: 7447409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.
    Chin NX; Gu JW; Fang W; Neu HC
    Diagn Microbiol Infect Dis; 1992; 15(4):331-7. PubMed ID: 1611848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of a new quinolone, AM-1091.
    Neu HC; Novelli A; Chin NX
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1036-41. PubMed ID: 2675753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of cefmenoxime (SCE 1365)].
    Brun Y; Forey F; Coulet M; Fleurette J; Bryskier A
    Pathol Biol (Paris); 1983 May; 31(5):343-6. PubMed ID: 6312394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model.
    Shipman C; Smith SH; Drach JC; Klayman DL
    Antiviral Res; 1986 Jul; 6(4):197-222. PubMed ID: 3017201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.